Skip to main content
. 2019 Mar 14;25(10):1238–1247. doi: 10.3748/wjg.v25.i10.1238

Table 1.

Demographic and clinicopathologic characteristics n (%)

Overall (n = 1303) Recurrence (107) No recurrence (1196) OR (95%CI) P-value
Gender
Male 681 (52.3) 65 (60.7) 616 (51.5)
Female 622 (47.7) 42 (39.3) 580 (48.5) 0.686 (0.458, 1.028) 0.067
Age (yr)
Mean (SD) 55.77 (13.696) 55.76 (0.390) 55.83 (1.538) 1.000 (0.986, 1.015) 0.276
Tumor location
Gastric 873 (67.0) 38 (35.5) 835 (69.8)
Non-gastric 430 (33.0) 69 (64.5) 361 (30.2) 4.200 (2.774, 6.359) < 0.05
Follow-up period (mo)
Mean (SD) 64.91 (35.793) 75.36 (4.608) 63.98 (0.995) 1.008 (1.003, 1.013) < 0.05
Tumor size
Mean (SD) 5.14 (4.862) 9.01 (0.663) 4.80 (0.130) 1.128 (1.092, 1.165) < 0.05
≤ 5 cm 775 (59.5) 28 (26.2) 747 (62.5)
> 5 cm 528 (40.5) 79 (73.8) 449 (37.5) 4.694 (3.003, 7.337) < 0.05
Mitotic index
≤ 5/50 HPFs 877 (67.3) 44 (41.1) 833 (69.6)
> 5/50 HPFs 426 (32.7) 63 (58.9) 363 (30.4) 3.286 (2.193, 4.923) < 0.05
Tumor rupture
Yes 34 (2.6) 27 (25.2) 7 (0.6) 57.327 (24.220, 135.685)
No 1269 (97.4) 80 (74.8) 1189 (99.4) < 0.05
Modified NIH
Very low risk 347 (26.6) 14 (13.10) 333 (27.80) 0.182 (0.101, 0.329) < 0.05
Low risk 394 (30.2) 10 (9.30) 384 (32.10) 0.113 (0.057, 0.222) < 0.05
Intermediate risk 162 (12.4) 8 (7.50) 154 (12.90) 0.225 (0.106, 0.478) < 0.05
High risk 400 (30.7) 75 (70.10) 325 (27.20)
AFIP criteria
Very low risk 619 (47.5) 15 (14.00) 604 (50.50) 0.081 (0.045, 0.146) < 0.05
Low risk 250 (19.2) 16 (15.00) 234 (19.60) 0.224 (0.125, 0.401) < 0.05
Intermediate risk 173 (13.3) 15 (14.00) 158 (13.20) 0.311 (0.170, 0.568) < 0.05
High risk 261 (20.0) 61 (57.00) 200 (16.70)

OR: Odds ratio; CI: Confidence interval; SD: Standard deviation; HPF: High-power field; AFIP: Armed Forces Institute of Pathology; NIH: National Institutes of Health.